Imugene Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported net loss was AUD 39.17 million compared to AUD 37.87 million a year ago. Basic loss per share from continuing operations was AUD 0.0062 compared to AUD 0.0067 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.075 AUD | +7.14% | -8.54% | -31.82% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.82% | 362M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- IMU Stock
- News Imugene Limited
- Imugene Limited Reports Earnings Results for the Full Year Ended June 30, 2023